The store will not work correctly when cookies are disabled.
3,6-dichloro-9-(3-(4-methylpiperazin-1-yl)propyl)-9H-carbazole
ID: ALA5286133
Max Phase: Preclinical
Molecular Formula: C20H23Cl2N3
Molecular Weight: 376.33
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(CCCn2c3ccc(Cl)cc3c3cc(Cl)ccc32)CC1
Standard InChI: InChI=1S/C20H23Cl2N3/c1-23-9-11-24(12-10-23)7-2-8-25-19-5-3-15(21)13-17(19)18-14-16(22)4-6-20(18)25/h3-6,13-14H,2,7-12H2,1H3
Standard InChI Key: XHSLNZNYPXAQPS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.5868 -1.4521 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.0152 -1.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0152 -0.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3007 0.1153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5863 -0.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8021 -0.0421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3172 -0.7096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5026 -0.7954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8382 -1.5491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3532 -2.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4671 -2.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8021 -1.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5863 -1.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3007 -1.5346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6217 -2.8195 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.5460 0.7410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2615 0.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5180 1.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3257 1.8668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5833 2.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3908 2.8195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9408 2.2046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6833 1.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8758 1.2519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5868 2.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
12 13 1 0
13 5 2 0
13 14 1 0
14 2 2 0
10 15 1 0
6 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 19 1 0
22 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.33 | Molecular Weight (Monoisotopic): 375.1269 | AlogP: 4.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 11.41 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.69 | CX LogP: 4.45 | CX LogD: 3.14 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.65 | Np Likeness Score: -1.17 |
References
1. Clausen JD, Kjellerup L, Cohrt KO, Hansen JB, Dalby-Brown W, Winther AL.. (2017) Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives., 27 (19): [PMID:28893470] [10.1016/j.bmcl.2017.08.067] |